Skip to main content

Prescription medicine

Calcium chloride, potassium chloride, sodium chloride and sodium lactate

Calcium chloride, potassium chloride, sodium chloride and sodium lactate is a prescription medicine with an FDA approval on record since 1971. FDA's NDC Directory lists it from 2 generic labelers, and pharmacies paid $0.0038 per mL (Lactated ringers injection) in the October 7, 2026 NADAC survey.

  • Generic listed

Check it at the source: the calcium chloride, potassium chloride, sodium chloride and sodium lactate FDA label on DailyMed (effective October 29, 2025, Baxter Healthcare Company); the NDA 16682 record on Drugs@FDA; every calcium chloride, potassium chloride, sodium chloride and sodium lactate label on DailyMed.

Highlights of the record

FDA label of October 29, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026

Used for

From the label: indications and usage

Lactated Ringer’s Injection is indicated for use as a source of water and electrolytes or as an alkalinizing agent in adults and pediatric patients.

Forms and strengths

  • 0.6 g/100ml / 0.31 g/100ml / 0.03 g/100ml / 0.02 g/100ml
  • 6 g/1000ml / 3.1 g/1000ml / 300 mg/1000ml / 200 mg/1000ml
  • 600 mg/100ml / 310 mg/100ml / 30 mg/100ml / 20 mg/100ml
  • 600 mg/100ml / 310 mg/100ml / 20 mg/100ml / 30 mg/100ml

Injection (solution); irrigant; solution.

On the market

Earliest approval on file
March 22, 1971 Lactated Ringer'S In Plastic Container, Baxter Hlthcare; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals
1 first January 28, 2019; 1 with a marketed status in Drugs@FDA
Labelers listed (NDC)
8 of which 2 under generic applications, 6 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
$0.0038 per mL Lactated ringers injection
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
5 since 2024 3 Class I among all firms' recalls; latest August 12, 2026
FAERS reports
972 through July 30, 2026

What is calcium chloride, potassium chloride, sodium chloride and sodium lactate used for?

From the label: indications and usage

Lactated Ringer’s Injection is indicated for use as a source of water and electrolytes or as an alkalinizing agent in adults and pediatric patients. Lactated Ringer’s Injection is indicated for use as a source of water and electrolytes or as an alkalinizing agent in adults and pediatric patients.

FDA pharmacologic class: Blood Coagulation Factor, Osmotic Laxative, Phosphate Binder and Potassium Salt.

Source: FDA drug label (Lactated Ringers), Baxter Healthcare Company, effective October 29, 2025 (SPL set dad7735c-709b-40ea-ab7a-15577e24a966), via openFDA; the full label on DailyMed

Is there a generic for calcium chloride, potassium chloride, sodium chloride and sodium lactate?

The FDA approved the first generic calcium chloride, potassium chloride, sodium chloride and sodium lactate on January 28, 2019. 1 generic application is approved; 1 of it carries a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.

FDA's NDC Directory lists calcium chloride, potassium chloride, sodium chloride and sodium lactate from 2 labelers under a generic (ANDA) application and from 6 brand labelers. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.

  • 1971 earliest approval on file
  • 2019 first generic approved
  • red ticks recalls

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What do pharmacies pay for calcium chloride, potassium chloride, sodium chloride and sodium lactate?

In CMS's NADAC survey of October 7, 2026, pharmacies paid $0.0038 per mL (Lactated ringers injection), up 32% from $0.0029 on October 8, 2025. The survey records the price, not the reason for a change; large moves often follow a new generic or a list-price change. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.

  • Lactated ringers injection (generic)
$0.0046
$0.0029
July 2024October 2026
NADAC per unit, October 7, 2026
Strength and formBrand or genericPharmacy cost30 tablets, or one pen or vial12-month change
Lactated ringers injectionGeneric$0.0038 per mLn/a+32%

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

Has calcium chloride, potassium chloride, sodium chloride and sodium lactate been recalled?

The FDA's Enforcement Report lists 5 recalls naming calcium chloride, potassium chloride, sodium chloride and sodium lactate since 2024: 3 Class I (the most serious), 2 Class II, 0 Class III; 4 still ongoing. A recall names products and lots, not every product of the medicine.

StartedClassCompanyReason
August 12, 2026Class IB BRAUN MEDICAL INCPresence of Particulate matter.
April 28, 2026Class IB BRAUN MEDICAL INCPresence of Particulate Matter.
August 18, 2025Class IB BRAUN MEDICAL INCPresence of Particulate Matter
August 4, 2025Class IIB BRAUN MEDICAL INCLack of Assurance of Sterility; potential for fluid leakage at one of the weld sites.
March 22, 2024Class IIB. Braun Medical IncLack of assurance of sterility: bags have the potential to leak..

Source: FDA Enforcement Report (drug recalls) via openFDA, through October 8, 2026

What does the calcium chloride, potassium chloride, sodium chloride and sodium lactate label say about other medicines?

The calcium chloride, potassium chloride, sodium chloride and sodium lactate label names 13 other medicines in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine namedSectionWhat the label says
Amiloridedrug interactionsThe risk of hyperkalemia is increased in patients treated with agents or products that can cause hyperkalemia or increase the risk of hyperkalemia, such as potassium-sparing diuretics (amiloride, spironolactone, triameterene), with ACE inhibitors, angiotensin II receptor antagonists, or the immunosuppressants …
Argininedrug interactionsThese drugs include diuretics and those that cause SIADH (e.g., arginine vasopressin analogs, certain antiepileptic, psychotropic, or cytotoxic drugs).
CeftriaxonecontraindicationsCONTRAINDICATIONS Lactated Ringer’s Injection is contraindicated in: Neonates (28 days of age or younger) who are receiving concomitant treatment with ceftriaxone, even if separate infusion lines are used, due to the risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream [see Warnings and …
Corticotropindrug interactionsHypernatremia and Fluid Retention Administration of Lactated Ringer’s Injection to patients treated concomitantly with drugs associated with sodium and fluid retention (e.g., corticosteroids or corticotropin) may increase the risk of hypernatremia and volume overload.
Cyclosporinedrug interactions… triameterene), with ACE inhibitors, angiotensin II receptor antagonists, or the immunosuppressants tacrolimus and cyclosporine.
Dextroamphetaminedrug interactionsRenal clearance of alkaline drugs, such as sympathomimetics (e.g., ephedrine, pseudoephedrine), dextroamphetamine (dexamphetamine) sulfate, and fenfluramine (phenfluramine) hydrochloride may be decreased.
Digoxindrug interactionsDigoxin: consider reducing the volume or rate of Lactated Ringer’s Injection due to the increased risk of digoxin toxicity with calcium-containing solutions.
Ephedrinedrug interactionsRenal clearance of alkaline drugs, such as sympathomimetics (e.g., ephedrine, pseudoephedrine), dextroamphetamine (dexamphetamine) sulfate, and fenfluramine (phenfluramine) hydrochloride may be decreased.
Fenfluraminedrug interactionsRenal clearance of alkaline drugs, such as sympathomimetics (e.g., ephedrine, pseudoephedrine), dextroamphetamine (dexamphetamine) sulfate, and fenfluramine (phenfluramine) hydrochloride may be decreased.
Lithiumdrug interactionsIf concomitant use is unavoidable, monitor serum lithium concentrations more frequently.
Pseudoephedrinedrug interactionsRenal clearance of alkaline drugs, such as sympathomimetics (e.g., ephedrine, pseudoephedrine), dextroamphetamine (dexamphetamine) sulfate, and fenfluramine (phenfluramine) hydrochloride may be decreased.
Spironolactonedrug interactionsThe risk of hyperkalemia is increased in patients treated with agents or products that can cause hyperkalemia or increase the risk of hyperkalemia, such as potassium-sparing diuretics (amiloride, spironolactone, triameterene), with ACE inhibitors, angiotensin II receptor antagonists, or the immunosuppressants …
Tacrolimusdrug interactions… spironolactone, triameterene), with ACE inhibitors, angiotensin II receptor antagonists, or the immunosuppressants tacrolimus and cyclosporine.

Check calcium chloride, potassium chloride, sodium chloride and sodium lactate against other medicines

Source: FDA drug label (Lactated Ringers), Baxter Healthcare Company, effective October 29, 2025 (SPL set dad7735c-709b-40ea-ab7a-15577e24a966), via openFDA; the full label on DailyMed

What do FAERS reports show for calcium chloride, potassium chloride, sodium chloride and sodium lactate?

The FDA Adverse Event Reporting System holds 972 reports that list calcium chloride, potassium chloride, sodium chloride and sodium lactate among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 111 are coded as a death and 298 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

Reports received each year

The most reported reactions

  • Acute Kidney Injury63
  • Dyspnoea (named in the label)63
  • Tachycardia (named in the label)53
  • Blindness50
  • Hypotension (named in the label)47
  • Pruritus (named in the label)43
  • Pain38
  • Chills33

Side effects: the label's list and every FAERS reaction

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Other blood coagulation factors
the pharmacologic class, with prices and generics
Check an interaction
what two or more labels say about each other